Buy, Hold, Sell: Sonic Healthcare, Amp, Cba Shares

S&P/ASX 200 Index (ASX: XJO) shares fell 1.6% to close at 9,115.2 points last Friday.

Let's start the new week with some fresh ratings from the experts (courtesy The Bull). 

Sonic Healthcare Ltd (ASX: SHL)

The Sonic Healthcare share price edged 0.1% lower to $22.37 last week.

Bell Potter has a buy rating on this ASX 200 healthcare share.

Analyst Martyn Jacobs said: 

SHL is trading close to decade lows on an EV/EBITDA basis and is relatively well priced against its domestic large cap healthcare peers, with a FY27e PE of c.16x being amongst the lowest in the peer group.

We would expect that should the recent recovery in large cap healthcare valuations continue, it would be a tailwind for SHL, particularly if it can impress in the forthcoming business update and the CEO impresses investors, despite being early in his tenure.

The ASX 200 healthcare sector fell to a nine-year low in June before pivoting and rebounding 30% to date.

AMP Ltd (ASX: AMP)

The AMP share price fell 0.9% to $2.33 last week.

This month, AMP reported a 33% increase in underlying net profit after tax (NPAT) to $174 million for 1H FY26.

Andrew Wielandt from DP Wealth Advisory has a hold rating on this ASX 200 financial share. 

Wielandt said: 

Investors responded positively to the wealth management giant's first half result in fiscal year 2026. Statutory net profit after tax of $154 million was up 57 per cent. Underlying net profit after tax of $174 million increased 33 per cent. Assets under management increased to $167.6 billion.

The company announced an additional on-market share buy-back of $150 million and an interim dividend of 3 cents a share.

The company is focusing on delivering improving returns to shareholders.

AMP remains a hold subject to continuing favourable market conditions.

Commonwealth Bank of Australia (ASX: CBA)

The CBA share price fell 4.1% to $167.17 last week.

CBA reported a 7% increase in cash NPAT to $11 billion and a final dividend of $2.70 for FY26.

Arthur Garipoli from Dolphin Partners has a sell rating on this ASX 200 bank share.

Garipoli said: 

Cash net profit after tax of $10.982 billion in full year 2026 was up 7 per cent on the prior corresponding period. The net interest margin of 2.05 per cent was down 3 basis points.

The bank acknowledged growth is slowing in response to higher interest rates and inflation placing uneven pressure on household incomes and economic activity.

Home loan applications since the federal budget in May fell 15 per cent. 

CBA is a high quality bank, but an uncertain Australian economy leaves a challenging outlook at this point.

We believe the bank is trading on a stretched valuation, so it may be prudent to lock in some profits.

The post Buy, hold, sell: Sonic Healthcare, AMP, CBA shares appeared first on The Motley Fool Australia.

More reading

• Which is the best Vanguard ETF? VAS, VGS and VDHG compared
• If I invest $5,000 in CBA shares, how much passive income will I get in FY27?
• Why I'd buy these 2 ASX ETFs for $10,000 a year in passive income
• Here's how much CBA shares would have to fall for a 4% dividend yield
• 8 ASX 200 shares with fresh buy ratings this week

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Sonic Healthcare. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.